These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38352150)

  • 1. Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive
    Hamad Y; Nickel KB; Olsen MA; George IA
    Open Forum Infect Dis; 2024 Feb; 11(2):ofad662. PubMed ID: 38352150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Outpatient Parenteral Antimicrobial Therapy With Ceftriaxone for Methicillin-Susceptible
    Hamad Y; Connor L; Bailey TC; George IA
    Open Forum Infect Dis; 2020 Sep; 7(9):ofaa341. PubMed ID: 32908944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Rao SN; Rhodes NJ; Lee BJ; Scheetz MH; Hanson AP; Segreti J; Crank CW; Wang SK
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5232-8. PubMed ID: 26077253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible
    Ganguly A; de la Flor C; Alvarez K; Brown LS; Mang NS; Smartt J; King H; Perl TM; Filizola H; Bhavan KP
    Ann Pharmacother; 2023 Apr; 57(4):425-431. PubMed ID: 35942602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible
    Beganovic M; Cusumano JA; Lopes V; LaPlante KL; Caffrey AR
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz270. PubMed ID: 31281864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
    McDanel JS; Roghmann MC; Perencevich EN; Ohl ME; Goto M; Livorsi DJ; Jones M; Albertson JP; Nair R; O'Shea AMJ; Schweizer ML
    Clin Infect Dis; 2017 Jul; 65(1):100-106. PubMed ID: 28379314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
    Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Miller MA; Fish DN; Barber GR; Barron MA; Goolsby TA; Moine P; Mueller SW
    J Microbiol Immunol Infect; 2020 Apr; 53(2):321-327. PubMed ID: 30190234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting.
    Youngster I; Shenoy ES; Hooper DC; Nelson SB
    Clin Infect Dis; 2014 Aug; 59(3):369-75. PubMed ID: 24785233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
    Burrelli CC; Broadbent EK; Margulis A; Snyder GM; Gold HS; McCoy C; Mahoney MV; Hirsch EB
    Chemotherapy; 2018; 63(6):345-351. PubMed ID: 30965335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible
    Alsowaida YS; Benitez G; Bin Saleh K; Almangour TA; Shehadeh F; Mylonakis E
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
    Flynt LK; Kenney RM; Zervos MJ; Davis SL
    Infect Dis Ther; 2017 Jun; 6(2):225-231. PubMed ID: 28265972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
    Yetmar ZA; Khodadadi RB; Go JR; Chesdachai S; Abu Saleh OM
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):423-430. PubMed ID: 36800065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis.
    Yetmar ZA; Razi S; Nayfeh T; Gerberi DJ; Mahmood M; Abu Saleh OM
    Int J Antimicrob Agents; 2022 Jan; 59(1):106486. PubMed ID: 34839007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twice daily cefazolin is effective for treatment of serious methicillin-sensitive
    Birrell MT; Fuller A
    Ther Adv Infect Dis; 2019; 6():2049936119882847. PubMed ID: 31839941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.
    Lee B; Tam I; Weigel B; Breeze JL; Paulus JK; Nelson J; Allison GM
    J Antimicrob Chemother; 2015 Aug; 70(8):2389-96. PubMed ID: 26024869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.
    Wynn M; Dalovisio JR; Tice AD; Jiang X
    South Med J; 2005 Jun; 98(6):590-5. PubMed ID: 16004164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia.
    Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP
    J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
    BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
    Chan M; Ooi CK; Wong J; Zhong L; Lye D
    BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.